Goldfinch Bio

Last updated: October 09, 2024

Anthony Johnson, CEO
Anthony Johnson, CEO
USA | Funding: $210M (+)

Website: https://www.goldfinchbio.com

Goldfinch is singularly focused on discovering and developing precision therapies for patients with kidney disease.